W., Rudel, L
Ozempic, prescribed for type 2 diabetes, earned its FDA approval in 2017, and Wegovy, prescribed for chronic weight management, became FDA-approved in 2021
Here, we absolutely must credit the brave and persistent scientists at Amylin and then Eli Lilly who got us the Exenatite approved for Type 2 diabetes in 2005, followed by the absolute blockbuster, Tirzepatide (GLP-1 + GIP)
For Ozempic, the most commonly reported side effects include: nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
Research has shown that Se supplementation can improve thyroid function in areas with iodine deficiency, suggesting that Se not only enhances the conversion of T4 to T3 but also supports overall thyroid health [91]